Day: August 27, 2021
CALGARY, Alberta, Aug. 27, 2021 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB, SUGR.WR, SUGR.WS, SUGR.WT) (OTCQB: SBUDF) (“Sugarbud” or the “Company“) is pleased to announce that it has entered into a Sales, Marketing, Supply and Distribution agreement (the “Agreement“) with ROSE LifeScience Inc. (“ROSE“) for the Province of Québec.
Supply Agreement
Under the terms of the Agreement, Sugarbud will be partnering with ROSE to bring Sugarbud grown premium craft cannabis to the province of Québec under the ROSE brand ELEKT Cannabis. The Agreement with ROSE is subject to customary regulatory and new product notification requirements.
“We are thrilled to be partnering with ROSE to bring select Sugarbud grown premium craft cannabis strains to the province of Québec...
Arco Vara AS changes the location of the head office
Written by Customer Service on . Posted in Public Companies.
From today, the head office of Arco Vara AS is located in Tallinn at Maakri Str 30, 11th floor. In relation to that, from 27 August 2021, the legal address of Arco Vara AS is Maakri Str 30, 10145 Tallinn.Tiina Malm
CFO
Arco Vara AS+372 614 4630tiina.malm@arcovara.com
Quantum Genomics Presents Results from Phase IIb QUORUM Study of Firibastat in Heart Failure at the European Society of Cardiology Meeting
Written by Customer Service on . Posted in Public Companies.
Firibastat is as efficient as the current standard of care (ramipril) in preventing the degradation of the left ventricular ejection fraction (primary endpoint) after myocardial infarction in full study population
Firibastat demonstrated better efficacy compared to ramipril in severe patients with low ejection fraction
Firibastat improved blood pressure profile in study population
Good safety profile observed from two doses of firibastatPARIS, Aug. 27, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, today announced results of the Phase IIb QUORUM study were presented by Prof. Gilles Montalescot (Paris) on...
Genmab to Present at Morgan Stanley 19th Annual Global Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
Media Release
Copenhagen, Denmark, 27 August, 2021
Genmab A/S (Nasdaq: GMAB) announced today that its CEO, Jan van de Winkel, Ph.D. will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 8:00 AM EDT / 2:00 PM CEST on September 9, 2021. A webcast of the event, which will include brief opening remarks followed by a question-and-answer session, will be available on Genmab’s website at https://ir.genmab.com/events-and-presentations#content
About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation...
Himax Technologies, Inc. to Attend Deutsche Bank dbAccess IAA Cars Virtual Conference 2021 on September 6 – September 7, 2021
Written by Customer Service on . Posted in Public Companies.
TAINAN, Taiwan, Aug. 27, 2021 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that the Company will attend Deutsche Bank dbAccess IAA Cars Virtual Conference 2021 on September 6 – September 7, 2021.
The Company management will host meetings with interested investors during the conference dates. Conference participation is by invitation only and registration is mandatory. For more information on the conference or to schedule a one-on-one or group meeting, please contact a Deutsche Bank representative or the conference coordinator at: dbAccess.cars@db.com
About Himax Technologies, Inc.
Himax Technologies, Inc. (NASDAQ: HIMX) is a fabless semiconductor solution provider dedicated to display...
Prospect Ridge Resources Corp. Announces Property Option Agreement; $6 Million Non-Brokered Private Placement; and Appoints Former CEO and Chairman of Fortuna Silver Mines Inc. as Chief Executive Officer
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Aug. 27, 2021 (GLOBE NEWSWIRE) — Prospect Ridge Resources Corp. (CSE:PRR) (the “Company” or “Prospect“) is pleased to announce that it has entered into a property option agreement with Loan Wolf Exploration Ltd. (“Loan Wolf”) dated August 26, 2021 (the “Agreement“), pursuant to which the Company has acquired options to purchase a 100% interest in and to certain mineral claims and placer claims collectively known as the Holy Grail Property (the “Property”). Such options are comprised of: (1) an option to purchase 50% of the mineral claims comprising the Property (the “First Option”); (2) an option to purchase the remaining 50% of the mineral claims comprising the Property (the “Second Option”); and (3) an option (the “Placer Option” and, together with the First Option...
On the statement of the majority shareholder of AB “Ignitis grupė”
Written by Customer Service on . Posted in Public Companies.
On the statement of the majority shareholder of AB “Ignitis grupė” with a proposal to distribute dividends for the first half of 2021
AB “Ignitis grupė” (hereinafter – Ignitis Group or the Company) informs that on 27 August 2021 it received a statement from the Ministry of Finance of Republic of Lithuania, who owns 73.08% of Company’s shares, (hereinafter – the Majority Shareholder) with a proposal to distribute dividends to shareholders of the Company for the first half of 2021.
The Majority Shareholder has submitted the statement in accordance with Article 601 of the Law on Companies of the Republic of Lithuania as well as the Divided Policy of the Company, which stipulates that EUR 85 million shall be distributed in dividends for the financial year of 2020, and for every consecutive year the dividends shall increase by at least 3%,...
On the statement of the majority shareholder of AB “Ignitis grupė” with a proposal to distribute dividends for the first half of 2021
Written by Customer Service on . Posted in Public Companies.
AB “Ignitis grupė” (hereinafter – Ignitis Group or the Company) informs that on 27 August 2021 it received a statement from the Ministry of Finance of Republic of Lithuania, who owns 73.08% of Company’s shares, (hereinafter – the Majority Shareholder) with a proposal to distribute dividends to shareholders of the Company for the first half of 2021.
The Majority Shareholder has submitted the statement in accordance with Article 601 of the Law on Companies of the Republic of Lithuania as well as the Divided Policy of the Company, which stipulates that EUR 85 million shall be distributed in dividends for the financial year of 2020, and for every consecutive year the dividends shall increase by at least 3%, compared to the amount paid for the previous financial year. Respectively, the amount to be paid for the first half of 2021 is equal to...
Unibel – Obtention de l’autorisation de la Commission européenne relative à la cession de la marque Leerdammer® et de tous ses droits attachés
Written by Customer Service on . Posted in Mergers And Acquisitions.
Obtention de l’autorisation de la Commission européenne relative à la cession de la marque Leerdammer® et de tous ses droits attachés
Suresnes, le 27 août 2021
La Commission européenne a autorisé sans réserve au titre du contrôle des concentrations le projet de cession de Leerdammer1 à Lactalis annoncé le 19 mars dernier. Cette décision constitue une nouvelle étape dans le processus de finalisation de l’opération.
La réalisation définitive de l’opération devrait intervenir le 30 septembre 2021, conformément aux termes de l’accord d’échange signé le 13 juillet 2021 suite à l’obtention d’un avis favorable unanime des instances représentatives du personnel devant être consultées dans le cadre de l’opération.
Le Groupe Bel tiendra le marché informé de toute évolution significative relative à l’opération ainsi qu’aux opérations d’offres publiques...
Bel – Obtention de l’autorisation de la Commission européenne relative à la cession de la marque Leerdammer® et de tous ses droits attachés
Written by Customer Service on . Posted in Mergers And Acquisitions.
Obtention de l’autorisation de la Commission européenne relative à la cession de la marque Leerdammer® et de tous ses droits attachés
Suresnes, le 27 août 2021
La Commission européenne a autorisé sans réserve au titre du contrôle des concentrations le projet de cession de Leerdammer1 à Lactalis annoncé le 19 mars dernier. Cette décision constitue une nouvelle étape dans le processus de finalisation de l’opération.
La réalisation définitive de l’opération devrait intervenir le 30 septembre 2021, conformément aux termes de l’accord d’échange signé le 13 juillet 2021 suite à l’obtention d’un avis favorable unanime des instances représentatives du personnel devant être consultées dans le cadre de l’opération.
Le Groupe Bel tiendra le marché informé de toute évolution significative relative à l’opération ainsi qu’aux opérations d’offres publiques...